Usana Health Sciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Usana Health Sciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
USNA | Usana Health Sciences | $0.56 | $0.10 | — | — | $200.22M | $213.88M | — | — | 10/21/2025 | |
USNA | Usana Health Sciences | $0.54 | $0.54 | $0.74 | 37.04% | $212.87M | $225.20M | $235.85M | 4.73% | 07/22/2025 | |
USNA | Usana Health Sciences | $0.86 | $0.70 | $0.73 | 4.29% | $227.80M | $243.04M | $249.54M | 2.67% | 04/22/2025 | |
USNA | Usana Health Sciences | $0.87 | $0.49 | $0.64 | 30.61% | $221.08M | $208.82M | $213.61M | 2.30% | 02/25/2025 | |
USNA | Usana Health Sciences | $0.59 | $0.48 | $0.56 | 16.67% | $213.37M | $205.77M | $200.22M | -2.70% | 10/22/2024 | |
USNA | Usana Health Sciences | $0.89 | $0.65 | $0.54 | -16.92% | $238.20M | $220.99M | $212.87M | -3.67% | 07/23/2024 | |
USNA | Usana Health Sciences | $0.95 | $0.69 | $0.86 | 24.64% | $248.36M | $226.92M | $227.80M | 0.39% | 04/30/2024 | |
USNA | Usana Health Sciences | $0.66 | $0.52 | $0.87 | 67.31% | $227.96M | $212.82M | $221.08M | 3.88% | 02/06/2024 | |
USNA | Usana Health Sciences | $0.78 | $0.64 | $0.59 | -7.81% | $233.30M | $220.41M | $213.37M | -3.20% | 10/24/2023 | |
USNA | Usana Health Sciences | $1.00 | $0.70 | $0.89 | 27.14% | $264.47M | $231.14M | $238.20M | 3.06% | 07/25/2023 | |
USNA | Usana Health Sciences | $1.15 | $0.77 | $0.95 | 23.38% | $272.87M | $240.22M | $248.36M | 3.39% | 04/25/2023 | |
USNA | Usana Health Sciences | $1.03 | $0.35 | $0.66 | 88.57% | $267.30M | $203.79M | $227.96M | 11.86% | 02/07/2023 | |
USNA | Usana Health Sciences | $1.36 | $0.92 | $0.78 | -15.22% | $274.35M | $245.95M | $233.30M | -5.14% | 10/25/2022 | |
USNA | Usana Health Sciences | $1.87 | $1.13 | $1.00 | -11.50% | $336.84M | $268.45M | $264.47M | -1.48% | 07/26/2022 | |
USNA | Usana Health Sciences | $1.45 | $1.14 | $1.15 | 0.88% | $307.98M | $267.31M | $272.87M | 2.08% | 04/26/2022 | |
USNA | Usana Health Sciences | $1.87 | $1.28 | $1.03 | -19.53% | $310.52M | $271.93M | $267.30M | -1.70% | 02/08/2022 | |
USNA | Usana Health Sciences | $1.44 | $1.30 | $1.36 | 4.62% | $298.51M | $268.06M | $274.35M | 2.35% | 10/26/2021 | |
USNA | Usana Health Sciences | $1.32 | $1.71 | $1.87 | 9.36% | $258.99M | $332.61M | $336.84M | 1.27% | 07/27/2021 | |
USNA | Usana Health Sciences | $1.23 | $1.48 | $1.45 | -2.03% | $266.62M | $301.47M | $307.98M | 2.16% | 04/27/2021 | |
USNA | Usana Health Sciences | $1.41 | $1.43 | $1.87 | 30.77% | $271.30M | $291.54M | $310.52M | 6.51% | 02/09/2021 | |
USNA | Usana Health Sciences | $1.09 | $1.25 | $1.44 | 15.20% | $260.60M | $277.26M | $298.51M | 7.67% | 10/20/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-22 | $0.74 | $0.54 | 37.0 % |
Q1 | 2025-04-22 | $0.73 | $0.70 | 4.29 % |
Q4 | 2025-02-25 | $0.64 | $0.49 | 30.6 % |
Q3 | 2024-10-22 | $0.56 | $0.48 | 16.7 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-22 | $235.85M | $225.20M | 4.73 % |
Q1 | 2025-04-22 | $249.54M | $243.04M | 2.67 % |
Q4 | 2025-02-25 | $213.61M | $208.82M | 2.30 % |
Q3 | 2024-10-22 | $200.22M | $205.77M | -2.70 % |
Si prevede che Usana Health Sciences (USNA) fornisca risultati il ottobre 21, 2025. Gli ultimi risultati sono stati pubblicati il luglio 22, 2025 per il Q2.
L'EPS effettivo era $0.74, che superato la stima di $0.54.
Le entrate effettive sono state $235.8M, che superato la stima di $225.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.